Correlation Between Kiora Pharmaceuticals and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Entero Therapeutics,, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Entero Therapeutics,.
Diversification Opportunities for Kiora Pharmaceuticals and Entero Therapeutics,
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Kiora and Entero is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Entero Therapeutics,
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the Entero Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Kiora Pharmaceuticals is 1.35 times less risky than Entero Therapeutics,. The stock trades about -0.08 of its potential returns per unit of risk. The Entero Therapeutics, is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 54.00 in Entero Therapeutics, on November 18, 2024 and sell it today you would lose (3.00) from holding Entero Therapeutics, or give up 5.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Entero Therapeutics,
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Entero Therapeutics, |
Kiora Pharmaceuticals and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Entero Therapeutics,
The main advantage of trading using opposite Kiora Pharmaceuticals and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Entero Therapeutics, vs. Crinetics Pharmaceuticals | Entero Therapeutics, vs. Rhythm Pharmaceuticals | Entero Therapeutics, vs. Kura Oncology | Entero Therapeutics, vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |